Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mitomycin C Timing in Trabeculectomy
NCT01297803Phase 2Unknown
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Nov 2010
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of mitomycin c in Glaucoma (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Corneal Endothelial Cell Density at 6 months, Corneal Endothelial Cell Polymorphism at 6 months and 1 more. Status: unknown.
02
Drugs
mitomycin c
03
Conditions
Glaucoma
Beyond the preview
Go deeper on NCT01297803.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01297803.